News
Polio, Prices, and Policies: Navigating Public Health in Early 2026
As we settle into Mid-March 2026, the landscape of U.S. public health is marked by a potent mix of ongoing challenges and pivotal regulatory developments. The intersection of global infectious threats, healthcare affordability struggles, and evolving drug and device oversight paints a complex canvas demanding clear-eyed attention. This week’s digest spans critical COVID-era carryovers, healthcare […]
Read more →